Ernest Pharmaceutical Private Limited

Potassium Chloride Injection Concentrate IP 150mg/ml is a sterile intravenous electrolyte formulation used for the treatment and prevention of hypokalemia in clinical and hospital settings. This concentrate is intended for dilution prior to intravenous infusion and must be administered under medical supervision.

The product is manufactured in compliance with Indian Pharmacopoeia (IP) standards and is widely supplied for institutional, hospital, and international export requirements. It is commonly used in fluid and electrolyte replacement therapy, post-operative care, and critical care treatment protocols.

Each pack contains 10ml ampoules ensuring accurate dosing and safe handling. Suitable for bulk supply, tenders, and export distribution.

Key Product Specifications 

 

• Active Ingredient: Potassium Chloride

• Strength: 150 mg/ml

• Dosage Form: Injection Concentrate

• Route: Intravenous Infusion (After Dilution)

• Packing: 10ml Ampoule (5 × 5 Ampoules)

• Pharmacopoeia Standard: IP

• Storage: Store below 25°C, protect from light

• Usage: Hospital & Institutional Use Only

Uses

• Treatment of potassium deficiency (hypokalemia)

• Electrolyte replenishment therapy

• IV fluid supplementation

• Critical care and post-operative support

Potassium Chloride Injection Exporter, Potassium Chloride IV Infusion, KCl Injection Concentrate, Electrolyte Injection Supplier, Potassium Chloride Injection IP Manufacturer, IV Potassium Injection Export, Hospital Electrolyte Solution

Cerebrolysin 10ml Injection is a clinically proven neuroprotective and neurotrophic medicine widely used in the treatment of neurological and cognitive disorders. It is a sterile solution for intravenous injection/infusion, manufactured under stringent pharmaceutical quality standards and supplied in 10ml ampoules.

Cerebrolysin contains a unique combination of low-molecular-weight neuropeptides and amino acids that mimic the action of natural neurotrophic factors. It supports brain cell regeneration, neuronal survival, and synaptic plasticity, making it highly effective in neurological recovery therapies.

🔹 Key Therapeutic Uses

• Ischemic & hemorrhagic stroke rehabilitation

• Alzheimer’s disease and other dementias

• Traumatic brain injury (TBI)

• Vascular dementia

• Cognitive impairment and memory disorders

• Neurodegenerative conditions

🔹 Product Specifications

• Product Name: Cerebrolysin® Solution for Injection

• Strength: 10ml

• Dosage Form: Injection (Solution)

• Route of Administration: Intravenous injection / infusion

• Packaging: 5 ampoules × 10ml

• Manufacturer: EVER Pharma

• Storage: Store below 25–30°C, protect from light

🔹 Key Benefits

• Enhances cognitive function and memory

• Promotes neuronal repair and regeneration

• Improves functional recovery after stroke

• Clinically trusted in neurology and psychiatry

• Suitable for hospital and institutional use

🔹 Supply & Export Information

We offer Cerebrolysin 10ml Injection for bulk supply, hospital procurement, and international export. Products are supplied with proper documentation, export-compliant packaging, and quality assurance.

📦 Available for: Bulk orders | Institutional supply | Global export
📑 Documentation: Invoice, Packing List (on request)